Sclerodermatous eruption in a patient with metastatic colon cancer treated with an FLT3/CDK inhibitor

Australas J Dermatol. 2023 Aug;64(3):e272-e274. doi: 10.1111/ajd.14093. Epub 2023 May 31.
No abstract available

Keywords: FLT3/CDK inhibitor; FN-1501; metastatic colon adenocarcinoma; scleroderma; systemic sclerosis (SSc); tyrosine kinase.

MeSH terms

  • Colonic Neoplasms* / drug therapy
  • Exanthema*
  • Humans
  • Protein Kinase Inhibitors / adverse effects
  • Scleroderma, Localized*
  • fms-Like Tyrosine Kinase 3


  • Protein Kinase Inhibitors
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3